“…One of the most important advances in the surgical treatment of pediatric cerebrovascular lesions has not been technical, but rather has consisted of clarification of operative indications based on data-driven guidelines. For AVMs, the controversial ARUBA (A Randomised trial of Unruptured Brain Arteriovenous malformations) trial had previously discouraged treatment of asymptomatic lesions, but recent analysis of the pediatric patients in this study actually strongly supports operative intervention – markedly reversing the initial consensus [ 20 , 22 , 34 , 48 ]. Additional studies, citing the expected long lifespan of children, the plasticity of pediatric neural pathways in recovering from treatment side effects and the improvement in surgical outcomes, have increasingly supported surgical treatment of pediatric AVMs in an expanding number of clinical scenarios, including many asymptomatic lesions (of note, radiosurgery, including Gamma Knife, remains an additional, well-documented treatment option for many AVMs) [ 10 , 20 , 22 , 48 ].…”